Peijia Medical Receives NMPA Approval for DCwire Micro Guide Wire Device in China

Peijia Medical Ltd (HKG: 9996), a leading Chinese firm in the neurointerventional field, has announced receiving market approval from the National Medical Products Administration (NMPA) in China for its DCwire micro guide wire device. This milestone marks the company’s 15th neurointerventional product approval in China, highlighting its commitment to advancing neurovascular care.

The DCwire Micro Guide Wire: Precision in Neurointerventional Surgery
The DCwire micro guide wire is a state-of-the-art neural intervention micro guide wire designed with the concept of “microstructure.” Microstructure design involves the creation of multi-layer microstructure instruments made from various materials using precision technology. Given the complex and slender nature of intracranial blood vessels, the manipulation of neural intervention instruments requires delicate handling and demands high precision in both design and manufacturing.

Excellence in Precision Control and Ease of Use
The DCwire micro guide wire has mastered the process accuracy of “microstructure” design and material characteristics, resulting in outstanding performance features such as precise control and ease of superselection. These attributes enable clinical doctors to quickly and conveniently establish surgical pathways during procedures, enhancing the efficiency and safety of neurointerventional surgeries.-Fineline Info & Tech

Insight, China's Pharmaceutical Industry